Wahle A, Lopez JJ, Pennington EC, Meeks SL, Braddy KC, Fox JM, Brennan TMH, Buatti JM, Rossen JD, Sonka M:


Estimating the Actual Dose Delivered by Intravascular Coronary Brachytherapy using Geometrically Correct 3-D Modeling.

In:

Galloway RL (ed):

Medical Imaging 2003: Visualization, Image-Guided Procedures, and Display.

SPIE Proceedings

Volume 5029, Page 129-137, 2003

Study on the impact of vessel curvature and eccentricity of the treatment catheter in intravascular brachytherapy, as derived from 3-D models obtained by fusion of intravascular ultrasound and biplane angiography (Paper) (Images) (Links)

Abstract: Intravascular brachytherapy has shown to reduce re-occurrence of in-stent restenosis in coronary arteries. For beta radiation, application time is determined from source activity and the angiographically estimated vessel diameter. Conventionally used dosing models assume a straight vessel with the catheter centered and a constant-diameter circular cross section. Aim of this study was to compare the actual dose delivered during in-vivo intravascular brachytherapy with the target range determined from the patient's prescribed dose. Furthermore, differences in dose distribution between a simplified tubular model (STM) and a geometrically correct 3-D model (GCM) obtained from fusion between biplane angiography and intravascular ultrasound were quantified. The tissue enclosed by the segmented lumen/plaque and media/adventitia borders was simulated using a structured finite-element mesh. The beta-radiation sources were modeled as 3-D objects in their angiographically determined locations. The accumulated dose was estimated using a fixed distance function based on the patient-specific radiation parameters. For visualization, the data was converted to VRML with the accumulated doses represented by color encoding. The statistical comparison between STM and GCM models in 8 patients showed that the STM significantly underestimates the dose delivered and its variability. The analysis revealed substantial deviations from the target dose range in curved vessels.